Westminster Health Forum

Improving access to medicine: pricing, regulation and implementing the Life Sciences Industrial Strategy

Morning, Thursday, 1st March 2018

Central London

THIS EVENT IS CPD CERTIFIED



Following the publication of the Life Sciences Industrial Strategy, delegates at this seminar will discuss the challenges and opportunities for improving access to medical treatments.


Planned sessions will focus on the expected Government response to recommendations in the Accelerated Access Review, including aligning the work of executive agencies through an Accelerated Access Partnership, encouraging local routes to market and improving NHS England’s commercial awareness - alongside addressing access in an early life sciences sector deal.


Further sessions will address the development of medicines regulation in light of the UK vote to leave the European Union and the possible relocation of the European Medicines Agency; key issues in using patient data to gauge the effectiveness of treatment and widen access - as well as priorities for increased funding for research and development.



Guest of Honour

Richard Torbett

Executive Director, Commercial Policy, UK and International, ABPI

Guest of Honour

Richard Torbett

Executive Director, Commercial Policy, UK and International, ABPI

Keynote Speakers

Dr Nicole Mather

Director, Office for Life Sciences

Dr Ian Hudson

Chief Executive, MHRA and Member (UK), Management Board, European Medicines Agency

Tim de Gavre

Country Head, Sandoz and Vice-Chair, British Generic Manufacturers Association

Chair

Daniel Zeichner MP

Speaker

Speaker confirmed from the Cystic Fibrosis Trust